0001354457-23-000043.txt : 20230125
0001354457-23-000043.hdr.sgml : 20230125
20230125092339
ACCESSION NUMBER: 0001354457-23-000043
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20230125
DATE AS OF CHANGE: 20230125
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: VIVEVE MEDICAL, INC.
CENTRAL INDEX KEY: 0000879682
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 043153858
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11388
BUSINESS ADDRESS:
STREET 1: 345 INVERNESS DRIVE SOUTH
STREET 2: BUILDING B, SUITE 250
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
BUSINESS PHONE: 4085301900
MAIL ADDRESS:
STREET 1: 345 INVERNESS DRIVE SOUTH
STREET 2: BUILDING B, SUITE 250
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
FORMER COMPANY:
FORMER CONFORMED NAME: PLC SYSTEMS INC
DATE OF NAME CHANGE: 19930328
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: The Nasdaq Stock Market LLC
DATE OF NAME CHANGE: 20060224
25-NSE
1
primary_doc.xml
X0203
0001354457
Nasdaq Stock Market LLC
0000879682
VIVEVE MEDICAL, INC.
001-11388
345 Inverness Drive, Building B
Suite 250
Englewood
CO
COLORADO
80112
408-530-1900
Common Stock
17 CFR 240.12d2-2(b)
Aravind Menon
Hearings Advisor
2023-01-25
EX-99.25
2
vivedelistreason.txt
Delisting Determination, The Nasdaq Stock Market, LLC, January 25, 2023,
Viveve Medical, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the common stock of Viveve Medical, Inc., effective at the
opening of the trading session on February 6, 2023.
Based on review of information provided by the Company, Exchange Staff
determined that the Company no longer qualified for listing on the
Exchange pursuant to Listing Rules 5550(a)(2) and 5550(b)(1).
The Company was notified of the Staff determination on November 29, 2022.
On December 5, 2022, the Company exercised its right to appeal the Staff
determination to the Listing Qualifications Hearings Panel (Panel)
pursuant to Rule 5815. On January 17, 2023, the Company informed the Panel
that it was formally withdrawing its appeal. The Company common stock was
suspended on January 19, 2023. The Staff determination to delist the Company
securities became final on January 19, 2023.